MSI-H/dMMR prevalence varies by age and sex in Japanese cancer cohort Skip to content The CRC Digest ◇ RESEARCH MSI-H/dMMR prevalence varies by age and sex in Japanese cancer cohort Study of 1,130 older patients (median age 78) with gastric, colorectal, and endometrial cancers characterized deficient mismatch repair protein expression patterns, informing immunotherapy eligibility in aging populations. (Jpn J Clin
Meta-Analysis Examines Fecal Immunochemical Test Accuracy Skip to content The CRC Digest ▪ SCREENING Meta-Analysis Examines Fecal Immunochemical Test Accuracy A systematic review and meta-analysis evaluated the diagnostic accuracy of quantitative fecal immunochemical tests (FIT) for colorectal cancer and advanced neoplasm, examining variations in performance by sex, geographic region, study design, FIT platform, and positivity threshold. (Cancer
Expert Consensus Calls for Sex and Gender-Tailored CRC Screening Skip to content The CRC Digest Expert Consensus Calls for Sex and Gender-Tailored CRC Screening An Italian consensus study from the AIOM-GISEG working group identified areas of expert agreement regarding the potential appropriateness and clinical relevance of sex and gender-tailored colorectal cancer screening strategies, noting that despite evidence of sex
Study reveals sex-specific metabolic comorbidity patterns in CRC patients Skip to content The CRC Digest Study reveals sex-specific metabolic comorbidity patterns in CRC patients Researchers explored sex-specific prevalence and co-occurrence of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease among CRC patients using electronic medical records. (Front Med) This content is informational only and does not constitute medical
Estrogen receptor may explain gender differences in early-onset CRC Skip to content The CRC Digest Estrogen receptor may explain gender differences in early-onset CRC A study identified estrogen receptor expression differences between male and female early-onset CRC patients. (Clinical Colorectal Cancer) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team.